Articles tagged with Embryonic Stem Cells
Researchers found that BERT and ERNI proteins interact to temporarily stop neural cell development, giving other cells a head-start in forming organs and skin. This discovery advances knowledge of stem cell behavior, with potential implications for medical research.
Research by University College London scientists reveals that BERT and ERNI proteins control brain development timing in vertebrates. By binding to the Sox2 gene, these proteins create a timing mechanism that gives the green light for neural cells to form the brain and nervous system.
Advances in genome sequencing and single-nucleotide polymorphisms have revealed the vast differences in human DNA, enabling researchers to identify disease-related genes and risk factors. The study also highlights the potential of 'copy number variants' and induced pluripotent stem cells to improve our understanding of genetic activity.
Researchers have developed four unique human parthenogenetic stem cell lines that are HLA-homozygous, reducing the risk of provoking an immune reaction. These lines can serve as a renewable source of transplantable cells for treating genetic and degenerative diseases.
Researchers at Imperial College London have successfully matured beating heart cells derived from embryonic stem cells, overcoming two significant obstacles in developing a stem cell heart patch. They also developed a biocompatible scaffold that can hold the new cardiomyocytes in place while they integrate into existing heart tissue.
Researchers at Cornell University and their colleagues discovered that implanting embryonic cardiac cells into mice with heart attacks prevented arrhythmias. The technique improved electrical connections between cells and activated transplanted cells, restoring heart function and reducing arrhythmia risk.
Researchers have discovered a novel method to produce dopamine cells for Parkinson's disease treatment by cultivating ventral midbrain neural stem cells with Wnt5a. This approach yielded substantial recovery in mice with PD-like disease, without tumor development.
Researchers at John Hopkins University used human embryonic stem cells to develop bone tissue that heals large skull defects in mice. The study demonstrates a potential application of hESC-derived mesenchymal cells in musculoskeletal tissue regeneration.
Researchers successfully produced stem cells from cloned monkey embryos using the non-invasive Oosight microscope, a crucial step towards developing medical therapies. The innovative technology allows for clear visualization and removal of genetic material, leading to a 100% success rate in therapeutic cloning.
Using adult human stem cells, researchers found that the treated hearts contained more blood vessels and exhibited increased DNA repair activity. The study suggests that these stem cells have an instant stimulating effect on surrounding heart tissue following transplantation.
Researchers have made a breakthrough in deriving functional heart cells from human embryonic stem cells, exhibiting excitation-contraction coupling and handling calcium ions. The finding offers hope for future use of stem cell treatment in patients with end-stage disease, potentially avoiding the need for heart transplants.
Researchers at UW-Madison have successfully reprogrammed skin cells into embryonic stem cells, potentially resolving the ethical controversy surrounding human embryonic stem cell research. This breakthrough could lead to a shift in government funding policies and pave the way for non-embryonic stem cell research.
Acclaimed stem cell researcher Shinya Yamanaka successfully reprograms human adult cells into pluripotent stem cells capable of developing into any cell type. This breakthrough accelerates the pace of stem cell research and holds promise for generating alternative sources of human pluripotent stem cells.
A team of University of Wisconsin-Madison researchers successfully reprogrammed human skin cells into cells indistinguishable from embryonic stem cells. This breakthrough could revolutionize the field of stem cell biology and provide a new source of stem cells for medical research.
Researchers have discovered a way to transform adult human skin cells into cells resembling embryonic stem cells, which can differentiate into various tissue types. The converted cells display physical and genetic features similar to those found in embryonic stem cells.
Scientists have created a human embryonic stem cell line from an embryo with the fragile X mutation, revealing early events associated with the disease. The study suggests that preventing epigenetic modifications may help rescue abnormal cells, paving the way for new therapeutic strategies.
Researchers at Dr. Liu et al. successfully differentiated primary pancreatic ductal epithelial cells into insulin-producing cells using the transfection of PDX-1, a promising approach to enhance islet cell output and meet clinical needs. This study suggests a future for many diabetic patients who need islets transplantation.
Scientists used a genetic tool to study human embryonic stem cell self-renewal and differentiation. They found that reducing or increasing the expression of oct4 gene induced differentiation, revealing a key difference in early human development regulation compared to mice.
Two new genes, Jmjd1a and Jmjd2c, play a crucial role in regulating self-renewal of embryonic stem cells. Their depletion promotes differentiation at the expense of self-renewal.
Researchers have found that adult stem cells do not rely on the protein Oct4 to remain undifferentiated. Studies using sensitive assays failed to detect Oct4 in these cells, revealing a different regulation of pluripotency in adult versus embryonic stem cells.
Researchers at A*STAR in Singapore discovered that epigenetic modifications influence gene expression in human embryonic stem cells. The study found that genes modified by H3K4me3 and H3K27me3 contain DNA recipes for protein proliferation and are crucial to sensory processes, immunity, and drug metabolism.
Embryonic stem cells exhibit improved development when subjected to moderate fluid motion, similar to the womb's gentle rocking motions. This phenomenon was discovered by accident using a lab shaker, offering a simpler method for producing healthier cells with reduced clumping and increased cell survival rates.
UCSF researchers have developed a new method to generate embryonic stem cells, eliminating the need for a foreign 'drug resistance' gene. This breakthrough accelerates research on disease development and patient-specific therapies.
Researchers have successfully grown cartilage-like cells from human embryonic stem cells using the Rice method. The study's results mimic different types of cartilage found in the human body, such as hyaline articular cartilage and fibrocartilage.
The new journal Stem Cell Research will cover all aspects of stem cell research, including embryonic stem cells, cancer stem cells, and developmental studies. It aims to disseminate the results of ongoing research in this rapidly expanding field, with a focus on high-quality peer-reviewed studies.
Autophagy plays a crucial role in removing dying embryonic stem cells during normal development, preventing detrimental inflammation. The study found that mouse embryos lacking autophagy genes had impaired signals for engulfment by healthy cells, leading to abnormal development.
Researchers have successfully identified reprogrammed cells in mice without using genetic markers, simplifying the process and potentially yielding a bountiful supply of custom human embryonic stem cells. This breakthrough brings human stem cell therapies closer to reality and eliminates one major hurdle to reprogramming human cells.
Researchers developed a method to create cardiac muscle cells from embryonic stem cells, which then survived and thrived in damaged rat hearts. The treatment showed promise in improving heart function and thickness of walls after a heart attack.
Researchers at BRIC, University of Copenhagen, identified a new gene family (UTX-JMJD3) controlling embryonic development and stem cell maintenance. The discovery may contribute to understanding cancer development and therapeutic use of stem cells.
Researchers have developed a method to produce highly pure and functional neurons from human embryonic stem cells, enabling the creation of models for studying neurological diseases such as Alzheimer's and Parkinson's. The new approach allows for the isolation of specific neuronal populations with defined biological properties.
Two NIH-approved embryonic stem cell lines were found to generate distinct types of neurons, differing in synapse formation and neurotransmitter usage. The discovery highlights the influence of culture conditions on human ES cells' developmental properties.
Researchers at Boston Children's Hospital and the Harvard Stem Cell Institute used genetic techniques to compare embryonic stem cells from different sources. They discovered that parthenogenetic embryonic stem cells have a distinct genetic signature reflecting their biological origins, setting the historical record straight for a now-d...
Researchers used genetic analysis to determine the origin of a widely disputed stem cell line. The study found that the cell line was derived from a parthenogenetic embryo, not somatic nuclear transfer as previously claimed.
Researchers at Forsyth Institute have identified a novel mechanism controlling adult stem cells, highlighting the importance of direct cell-to-cell communication. The study's findings suggest that gap junctions play a critical role in regulating stem cell behavior and tissue regeneration.
A study has discovered that many human genes hover between 'on' and 'off' in any given cell, failing to finish transcription but remaining primed. This vulnerability could explain why cells acquire new properties in diseases like cancer and diabetes.
Scientists at McMaster University have made a groundbreaking discovery about human embryonic stem cells, finding they can generate fuel to sustain themselves. This breakthrough has significant implications for future clinical therapy, as it could lead to the development of new treatments for diseases such as Parkinson's and diabetes.
A study by researchers at Duke University Medical Center and Johns Hopkins University found that 60% of infertile couples would be likely to donate unused embryos for stem cell research. The number of available embryos could be 10 times higher than previous estimates, resulting in a potential 100-fold increase in stem cell lines.
Researchers at Children's Hospital Boston have found a new way to increase stem cells in blood, suggesting a possible treatment to help patients recover their immune function more quickly. The discovery uses a small-molecule drug that enhances the blood-forming system.
Researchers successfully induced pluripotent cells from fibroblasts using four transcription factors, exhibiting properties similar to embryonic stem cells. These findings have significant implications for regenerative medicine and may pave the way for generating patient-specific stem cell lines directly from a person's own cells.
Researchers at Whitehead Institute successfully reprogrammed mature skin cells into pluripotent cells, identical to embryonic stem cells, without using eggs or destroying embryos. These cells can give rise to live mice and transmit their genetic material to subsequent generations.
Researchers at UCLA successfully reprogrammed normal tissue cells into cells with unlimited properties as embryonic stem cells, offering a promising alternative to current cloning methods. The breakthrough could lead to the creation of immune-compatible cells for disease treatment and regenerative therapies.
UCI will receive $3.9 million to enhance its core embryonic stem cell research laboratory and expand a training program for young scientists on research techniques involving human embryonic stem cells. The grant is part of $50 million in funding awarded to 17 institutions by the California Institute for Regenerative Medicine.
Researchers have successfully engineered adult stem cells from human cord blood to produce insulin, a potential breakthrough in treating type 1 diabetes. The discovery uses complex signals produced by embryonic mouse pancreas to direct adult stem cells into islet-like cells, producing C-peptide and insulin.
Researchers used embryonic stem cells to investigate how some tumours migrate to other parts of the body, making treatment more difficult. They found that a crucial change in cell behavior, known as epithelial-mesenchymal transition, allows cancer cells to move and spread.
Scientists at EMBL discovered that microtubule interactions with the cell cortex drive asymmetric cell division in nematode worms. The study reveals a pulling force generated by cortical filaments, which could apply to other organisms and contexts such as stem cell renewal.
A study by Dr. Mary J.C. Hendrix found that inhibiting Nodal signaling in aggressive melanoma cells can reverse their invasiveness and tumor formation, reverting them to a more benign skin cell type. This discovery provides a promising new target for regulating tumor progression and metastasis.
A recent study published in Cell Stem Cell found that nearly half of couples who underwent in vitro fertilization (IVF) chose to donate their surplus embryos for stem cell research. The key factor was a clear explanation of the options, which helped couples navigate the legal situation and address concerns about donation.
Researchers have developed an in vitro model of ALS using embryonic stem cells, providing insights into the disease's mechanisms. The studies suggest that astrocytes may be toxic to motor neurons in ALS, offering a potential target for new therapies.
The San Diego Consortium for Regenerative Medicine has received six grants totaling $16.479588 to conduct life-saving human embryonic stem cell research, including work on brain repair and spinal injuries. The consortium aims to develop cures and therapies for devastating diseases like Parkinson's and Alzheimer's.
Scientists at USC have identified a small molecule, IQ-1, that prevents embryonic stem cells from differentiating into specific cell types. This discovery allows for the potential growth of human stem cells without risk of contamination from mouse feeder cells.
Three UCI projects focus on mitochondria, spinal cord injuries and genetic manipulation of human embryonic stem cells. Researchers aim to develop therapies and treatments for degenerative diseases and cancers.
Researchers at Rockefeller University successfully differentiated embryonic stem cells into fully functional granule neurons, the most plentiful neuron in the cerebellum. This breakthrough study marks a significant step toward understanding how to regulate embryonic stem cells and potentially use them for cell replacement therapy.
Researchers used human embryonic stem cells to treat a degenerative disease in mice, demonstrating the first successful use of hESCs in a diseased brain. The treatment not only replaced damaged nerve cells but also boosted the brain's supply of an enzyme and reduced inflammation.
Mayo Clinic researchers successfully transplanted cardiac preprogrammed embryonic stem cells into diseased hearts, regenerating infarcted heart muscle without tumor formation. The study establishes a tumor-resistant approach to growing new heart tissue from an embryonic stem cell source.
Researchers at UT-Houston's Brown Foundation Institute of Molecular Medicine have developed a new procedure to differentiate human embryonic stem cells into alveolar epithelial type II cells, also known as the 'stem cells of the lungs'. These cells can potentially be used to treat pulmonary genetic diseases and lung trauma.
Researchers have developed a technique to encourage survival and growth of adult stem cells, found in many tissues, which hold great promise for treating injuries and some diseases. The study's findings suggest that by manipulating the environment surrounding the cells, certain growth factors can protect them from pro-death signals.
Researchers from Baylor College of Medicine identify Sox17 as critical for transforming embryonic stem cells into cardiac mesoderm, the precursor to heart muscle. The discovery provides insight into generating cardiac muscle more effectively from embryonic stem cells.
Researchers identified Jumonji proteins essential for cellular differentiation, inactivating genes critical to embryogenesis. The study uses C. elegans and mouse embryonic stem cells, with potential applications in cancer treatment using inhibitors.
UCLA scientists have been awarded $4 million in seed grants to fund innovative research projects on human embryonic stem cells. The Institute for Stem Cell Biology and Medicine at UCLA will utilize these funds to explore various aspects of human embryonic development, immune response, and cell differentiation.
Researchers have discovered that aged, fertilization-failure mouse oocytes can be used as cytoplasmic donors in nuclear transfer procedures, paving the way for future human egg use. This breakthrough could optimize cloning protocols and reduce waste of discarded IVF eggs.